with Na2SO4, added to a final concentration of 180 g/L. The crude immunoglobulin fraction was collected by centrifligation at 9000 x g for 15 mm. After washing the precipitate once with a 180 g/L solution of Na2SO4, we dissolved it in Na2CO3 (50 mmollL, pH 9.8) and stored it at -20 #{176}C.
cation of HbF by radioimmunoassay (1, 12, 13) , which is considered accurate (9) but time consuming (12) . Monoclonal antibodies to the y-chain of HbF (14) and immunofluorescence have been used to detect and quantify fetal cells (15) . Recently, a sensitive enzyme-linked immunosorbent assay for HbF was developed with use of a y-specific monoclonal antibody (2).
We have developed a rapid and sensitive solid-phase immunometric assay for HbF in hemolysates, amniotic fluid, or plasma. The assay is based on two commercially available anti-HbF antibodies and time-resolved fluorometry. The sample volume is small and the assay procedure is simple and fast. The analytical range of the assay is large and well suited for clinical purposes.
Materials and Methods

Antibodies
We used rabbit polyclonal anti-human HbF IgG fraction (lot 106R) from New England Immunology Associates (Cambridge, MA) on the solid phase and a monoclonal antibody against the y-chain of human HbF (lot ; Accurate Chemical & Scientific Corp., Westbury, NY) as label. We purified the monoclonal antibody by precipitation with Na2SO4, added to a final concentration of 180 g/L. The crude immunoglobulin fraction was collected by centrifligation at 9000 x g for 15 mm. After washing the precipitate once with a 180 g/L solution of Na2SO4, we dissolved it in Na2CO3 (50 mmollL, pH 9.8) and stored it at -20 #{176}C.
Other antibodies tested were rabbit anti-human hemoglobin IgG (lot 027) from Dakopatts MS (Glostrup, Denmark), rabbit anti-human 
Statistical Methods
The reference interval was determined on the basis of the 2.5 and 97.5 percentiles, i.e., the central 95% reference interval.
Results
Development of the Assay
We studied 19 combinations of monoclonal and polyclonal antibodies to find a suitable pair ( Table 1) . Somewhat surprisingly, most antibody combinations gave a weak response with HbF. In nine of the assays (assays 5-9, 12, 14, 17, 18) the maximal signal was <10000 cps and in five others it was <100 000 cps (assays 1, 3, 10,  13, 15 ). This could result either from low antibody avidity or low titer of the polyclonal antisera. Assay 1 (i.e., the same polyclonal antibody to HbF both as solid phase and tracer antibody) did not give a sufficiently high signal, but when the antibody was further purified by affinity chromatography on HbF-Sepharose, a functioning assay was obtained (assay 2). However, the yield of specific antibody after purification was low, indicating low titer of the antiserum. We also obtained a good response with the same purified antibody on the solid phase and a polyclonal anti-HbA as tracer (assay 4). However, the assay also measured HbA0, indicating that this polyclonal anti-HbF was not sufficiently spe- 
Linearity,Precision,and AnalyticalRecovery
Samples of plasma, an erythrocyte hemolysate, and amniotic fluid diluted two-, four-, eight-, and 16-fold were assayed and compared with the undiluted samples.
The data from each sample were subjected to linearregression analysis ( Table 2 ). All samples showed acceptable linear response. The coefficients of intra-assay and interassay variation ranged from 5.1% to 13% and from 11% to 16%, respectively ( The between-run reproducibilitywas testedover 6 weeks. 'The hemolysateswere diluted 1:100 000.
determined in the presence of these hemoglobins, we found a negative interference. HbA0 had no effect on the measured HbF concentration when present at concentrations <0.3 mg/L; at 2 mg/L the analytical recovery of HbF decreased to 85%, and at higher concentrations of HbA0 the recovery of HbF dropped to 70%, apparently as a result of competition between HbA0 and HbF for binding to the solid-phase antibodies.
The same trend was seen in assay 16, which uses a monoclonal antibody to the 7-chain on the solid phase, although the interference was slightly smaller (Figure 3) . If samples assayed were diluted -50 000-fold, the results were corrected for this interference. At concentrations up to 0.1 mgiL, HbA2 and HbS, corresponding to 50% of total Hb, did not interfere with the determination of HbF.
Comparison with HPLC and Microcolumn Assay by HPLC (x) . We found good correlation: r = 0.982, y = 0.995 x + 1.467 ( Figure 4A) . The correlation at low concentrations of HbF was similar: r = 0.933,y = 1.17 x -0.17 ( Figure  4B ). The mean percentage of erythrocyte HbF for normal subjects was 0.34% by IFMA and 0.44% by HPLC. The mean values for samples from 43 cord blood hemolysates were 68% by IFMA and 67% by HPLC. In 10 cord blood samples HbF was also determined by the microcolumn method. The mean percentages were 73% by IFMA and 78% by microcolunin.
Reference Intervals for Erythrocytes and Plasma
The reference interval for plasma HbF of healthy women was 0.3-76 pgfL, the mean value was 38 pg/L 
DIscussIon
To our knowledge the present method is the first There is no high-dose "hook" effect up to 100 mg/L HbF (Figure 2) 
